Is RGNT diluting shareholders?

Read three numbers together: shares outstanding over time (5.2M as of 2025-12-31), warrants that can convert into new shares (11,310 reported), and how much cash runway remains (~64.38981818181819 months). A company short on cash with live registrations is structurally likely to issue shares.

Where do these numbers come from?

SEC EDGAR only: the XBRL company-facts API for shares, warrants and cash, and filing metadata for registrations and pricings. Every figure shows its source form, and nothing here is estimated by us beyond the arithmetic stated next to it.

Why might a warrant tranche be missing from the table?

The tranche table is built from the dimensions the company tagged in its own 10-Q or 10-K XBRL. A tranche the filer chose not to dimension does not appear, and its absence proves nothing: the exhibits remain the ground truth. Everything shown carries the filing it came from.

Dilution profile // every instrument, one screen, from SEC filings

REGENTIS BIOMATERIALS LTD. (RGNT)

CIK 1912966 · all EDGAR filings →

Overall dilution risk

MEDIUMworst of 3 computed signals (offering ability)

= the worst band among the computed sub-ratings, no hidden weighting

not every sub-rating was computable; treat as a floor

Offering ability

MEDIUM$16.3M registered

= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)

registered capacity, not remaining: amounts already taken down are not subtracted yet

Overhead supply

LOWwarrants = 0% of O/S

= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)

warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this

Historical dilution

NOT COMPUTEDunder 3 years of share history on file

= share count now vs 3 years ago

Cash need

LOW~64.4 months of runway

= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

Fewer than two cover-page share counts on file, so there is no history to chart.

Cash runway

Self-funding

generates cash

Full breakdown: cash runway tool

Warrants

Warrants outstanding: 11,310 underlying shares, as reported Dec 31, 2023 (20-F).

Reported exercise price: $0.004 (aggregate figure as tagged; individual tranches vary).

Balance-sheet fair value of warrants: $160,000 as of Dec 31, 2024.

Rough fully diluted estimate: 5.2M = 5.2M O/S + 11,310 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

The latest 10-Q/10-K instance document could not be checked just now, so nothing is shown rather than guessed. Try again shortly.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding	5.2M	Dec 31, 2025
+ Warrants (aggregate, as tagged) (if exercised)	11,310	Dec 31, 2023
Fully diluted estimate	5.2M	+0.2% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

Registered offering capacity on live registrations: $16.3Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

F-1Jul 8, 2026$16.3M registeredfiling →

Last 12 months: 0 executed · 6 registered.

UPDATEJul 13, 2026Prospectus update — often a resale registration, not necessarily new capital424B3 →

EFFECTIVEJul 13, 2026SEC declared a registration effective — selling can beginEFFECT →

REGISTEREDJul 8, 2026F-1 registration — capacity to sell shares, not a sale yetF-1 →

WITHDRAWNJun 15, 2026Registration withdrawnRW →

REGISTEREDJun 9, 2026F-1/A registration — capacity to sell shares, not a sale yetF-1/A →

MARKETINGMay 29, 2026Free-writing prospectus — offering being marketedFWP →

REGISTEREDMay 1, 2026F-1 registration — capacity to sell shares, not a sale yetF-1 →

UPDATEDec 4, 2025Prospectus update — often a resale registration, not necessarily new capital424B3 →

REGISTEREDOct 24, 2025F-1/A registration — capacity to sell shares, not a sale yetF-1/A →

MARKETINGOct 24, 2025Free-writing prospectus — offering being marketedFWP →

MARKETINGOct 6, 2025Free-writing prospectus — offering being marketedFWP →

REGISTEREDSep 30, 2025F-1/A registration — capacity to sell shares, not a sale yetF-1/A →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full RGNT workspace